Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
COLLEGIUM PHARMACEUTICAL, INC (COLL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026"
08/07/2023 8-K Other Events  Interactive Data
08/03/2023 8-K Investor presentation, Quarterly results
05/19/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/04/2023 8-K Investor presentation, Quarterly results
02/13/2023 8-K Quarterly results
02/06/2023 8-K Quarterly results
01/04/2023 8-K Quarterly results
12/22/2022 8-K Quarterly results
11/03/2022 8-K Quarterly results
08/04/2022 8-K Quarterly results
05/23/2022 8-K Quarterly results
05/13/2022 8-K/A Quarterly results
05/10/2022 8-K Quarterly results
04/13/2022 8-K Investor presentation
Docs: "Corporate presentation"
04/06/2022 8-K Appointed a new director
04/05/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Collegium Provides 2022 Financial Guidance"
03/23/2022 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financia...
Docs: "AMENDED AND RESTATED LOAN AGREEMENT",
"Collegium Completes the Acquisition of BDSI"
02/24/2022 8-K Quarterly results
02/14/2022 8-K Investor presentation
Docs: "Agreement and Plan of Merger, by and among Collegium Pharmaceutical, Inc., Bristol Acquisition Company Inc. and BioDelivery Sciences International, Inc",
"Form of Tender and Support Agreement, by and among Collegium Pharmaceutical, Inc., Bristol Acquisition Company Inc. and certain stockholders of BioDelivery Sciences International, Inc",
"Collegium to Acquire BioDelivery Sciences Broadening Pain Portfolio",
"Investor Presentation of Collegium Pharmaceutical, Inc."
12/28/2021 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Collegium Announces Settlement Framework to Resolve Pending Opioid-Related Litigation"
11/12/2021 8-K Cost Associated with Exit or Disposal Activities  Interactive Data
11/04/2021 8-K Quarterly results
09/30/2021 8-K Quarterly results
08/16/2021 8-K Quarterly results
08/05/2021 8-K Quarterly results
06/02/2021 8-K Quarterly results
05/24/2021 8-K Quarterly results
05/06/2021 8-K Quarterly results
02/25/2021 8-K Quarterly results
01/06/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Collegium Provides 2021 Financial Guidance"
12/30/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amended & Restated Employment Agreement, by and between Collegium Pharmaceutical, Inc. and Joseph Ciaffoni",
"Amended & Restated Employment Agreement, by and between Collegium Pharmaceutical, Inc. and Paul Brannelly",
"Amended & Restated Employment Agreement, by and between Collegium Pharmaceutical, Inc. and Scott Dreyer",
"Amended & Restated Employment Agreement, by and between Collegium Pharmaceutical, Inc. and Alison B. Fleming, Ph.D",
"Amended & Restated Employment Agreement, by and between Collegium Pharmaceutical, Inc. and Shirley Kuhlmann",
"Amended & Restated Employment Agreement, by and between Collegium Pharmaceutical, Inc. and Richard Malamut, M.D"
11/05/2020 8-K Quarterly results
09/30/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy